Investing Profile

William Greene

VC
Managing Director at MPM BioImpact
Photo of William Greene, Managing Director at MPM BioImpact

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Genentech Network
69 CONNECTIONS
Genentech Network
69 CONNECTIONS
Wesleyan University Network
45 CONNECTIONS
University of California, San Francisco Network
34 CONNECTIONS
University of California, San Francisco Network
34 CONNECTIONS
cb
MPM BioImpact Managing Director
6
CompanyStageDateRound SizeTotal Raised
Aeovian Pharmaceuticals
Series AMar 2024$50M
$140M
Co-investors: Richard Gaster (venBio Partners), Jens Eckstein (Apollo Health Ventures), Themasap Khan (Luma Group), Viktoriya Tigipko (TA Ventures)
Iconic Therapeutics
Series UnknownJun 2018$4M
Series CAug 2016$10M
Series CJan 2016$40M
Series BApr 2014$20M
$74M
Co-investors: Todd Foley (MPM BioImpact)
Aires Pharmaceuticals
Series BNov 2010$20M
$20M
Clinical Scientist GenentechPresent
MD Yale/UCSFPresent
Senior Clinical Scientist and Epidemiologist GenentechPresent
Assistant Clinical Professor of Medicine University of California, San FranciscoPresent
Managing Director MPM BioImpactPresent
Member Board Of Directors, Chairman of Investment Committee Global Health Investment FundPresent
Member Board Of Directors, Chairman of Investment Committee Global Health Investment CorporationPresent
Chairman of the Board Global Health Investment CorporationPresent
Board Member Maverick TherapeuticsPresent
Chief Investment Officer Hevolution FoundationPresent
Venture Partner MPM BioImpactPresent
Co-Founder University of California, San FranciscoPresent
Co-Founder Pear TherapeuticsPresent
Chariman and CEO Iconic Therapeutics, Inc.Present
CEO Iconic TherapeuticsPresent
Chief Executive Officer Fountain TherapeuticsPresent
Wesleyan University BA Biology
UCSF MD Medicine
University of California, San Francisco MD Medicine
Sign in with Google →
Sign in with Google →